Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Brain-iron cross talk / / edited by Wael Mohamed, Nicola Luigi Brogazzi, and Richard M. Kostrzewa
| Brain-iron cross talk / / edited by Wael Mohamed, Nicola Luigi Brogazzi, and Richard M. Kostrzewa |
| Pubbl/distr/stampa | Gateway East, Singapore : , : Springer, , [2023] |
| Descrizione fisica | 1 online resource (289 pages) |
| Disciplina | 599.0188 |
| Collana | Nutritional Neurosciences |
| Soggetto topico |
Iron - Physiological effect
Brain chemistry |
| ISBN | 981-19-7327-X |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Foreword -- Preface -- Acknowledgments -- Contents -- Editors and Contributors -- Part I: Iron, Brain Function and Behavior -- Chapter 1: Iron and Neuro-Cognition -- 1 Introduction -- 2 Delicate Regulation of Iron in the Brain -- 3 Iron Buildup and Neurodegenerative Diseases -- 3.1 Friedreich´s Ataxia -- 3.2 Wilson´s Disease -- 3.3 Alzheimer´s Disease (AD) -- 3.4 Case Study -- 4 Brain Running Short on Iron -- 4.1 Iron Deficiency and Neurotransmitters Synthesis, Signaling, and Energy Demand -- 4.2 Neurons Insulation (Myelination) -- 4.3 Developmental Delays -- 4.4 ADHD -- 4.5 RLS -- 4.6 Effect of Iron on the Dopaminergic and Serotonergic System -- 5 Brain Iron Research Has a Way to Go -- 6 Conclusion -- References -- Chapter 2: The Interplay between Iron and Oxidative Stress in Brain Neurodegenerative Diseases -- 1 Iron as an Essential Micronutrient -- 1.1 Introduction -- 1.2 Dietary Sources, Forms and Requirements of Iron -- 1.2.1 Iron Dietary Sources -- 1.2.2 Iron Forms -- 1.2.3 Human Requirements of Iron -- 1.3 Iron Bioavailability -- 1.4 Iron Metabolism -- 1.4.1 Iron Uptake, Absorption, and Transportation -- 1.4.2 Iron Utilization, Circulation, Reutilization, and Storage -- 1.4.3 Iron Excretion and Regulation -- 1.5 Brain Iron -- 2 Oxidative Stress, Iron Overload, and Brain Degenerative Diseases -- 2.1 The Concept of Oxidative Stress and Redox Signaling -- 2.2 The Crosstalk Between Iron and Redox Signaling and the Consequences of Iron Homeostasis Impairment -- 2.3 Iron Overload, Oxidative Stress, and Brain Degenerative Diseases (Selective Cases) -- 3 Conclusion -- References -- Chapter 3: Specific Nutritional Therapeutic Approaches Targeting Iron Overload and Other Hallmarks of Brain Degenerative Disea... -- 1 Therapeutic Opportunities from Nutritional Point of View -- 1.1 Introduction -- 1.2 Nutritional Therapeutic Opportunities.
1.2.1 Nutritional Treatment of Iron Overload -- Iron Chelators -- Natural Antioxidants -- 1.2.2 Diet Modification -- Diets Rich in Iron Chelators, Antioxidants, and Neurogenerative Molecules -- Caloric Restriction Diets -- Mediterranean Diet -- Gut Microbiota -- 2 Iron Between Deficiency and Overload -- 3 Conclusion -- References -- Chapter 4: Mediterranean Diet and Neuro-Cognition: Focus on Alzheimer Disease -- 1 Introduction -- 2 Mediterranean Diet and Cognitive Health -- 3 Mediterranean Diet and Alzheimer Disease -- 3.1 Fish, Dietary Fatty Acids and Risk of Cognitive Decline and Alzheimer´s Disease -- 3.2 Olive Oil and Risk of Cognitive Decline and Alzheimer´s Disease -- 3.3 Dairy Products and Risk of Cognitive Decline and Alzheimer´s Disease -- 3.4 Tea, Coffee and Risk of Cognitive Decline and Alzheimer´s Disease -- 3.5 Fruits, Vegetables and Risk of Cognitive Decline and Alzheimer´s Disease -- 4 Possible Mechanisms of Mediterranean Diet -- 5 Conclusion -- References -- Part II: Brain Disorders Related to Iron -- Chapter 5: The Critical Roleplay of Iron Neurochemistry in Progression of Parkinson´s Disease -- 1 Introduction -- 2 Brain Iron Transport -- 2.1 Overview of Iron Movement across Brain -- 2.2 Astrocyte Iron Movement -- 2.3 Oligodendrocytes (Transferrin Secretion) -- 2.4 Microglia -- 3 Iron Metabolism in Brain -- 3.1 Absorption -- 3.2 Storage -- 3.3 Brain Iron Toxicity and Accumulation -- 4 Gut Microbiota: A Bridging Stone Between Iron Metabolism and Neurodegeneration -- 5 Biochemical Pathways Accelerating Iron Aggregation -- 5.1 Disabled Iron Discharge -- 5.2 Modified Iron Deposition -- 5.3 Enhanced Iron Influx -- 6 Altered Neurobiology of Iron in PD -- 6.1 Abnormal Iron Homeostasis under Pathophysiological Condition of PD -- 6.2 Interconnection Between Iron and Alpha Synuclein -- 6.3 Ubiquitin-Proteasome System Induced Cell Death. 6.4 How Oxidative Stress Is Linked to Iron Imbalance -- 7 Ferroptosis -Cell Death Pathway in PD Utilizing Iron -- 8 Treatment Strategies for Parkinson´s Disease Targeting Iron Homeostasis -- 8.1 Iron Chelators: A Promising Treatment for PD -- 9 Conclusions and Future Prospects -- References -- Chapter 6: Iron-Calcium Crosstalk in Neurodegenerative Diseases -- 1 Introduction -- 2 Iron -- 2.1 Homeostasis and Repercussion of Altered Concentration of Brain Iron -- 2.2 Brain Anomalies and Iron -- 3 Calcium -- 3.1 Homeostasis and Repercussion of Altered Concentration of Brain Calcium -- 3.2 Brain Anomalies and Calcium -- 4 Calcium-Iron Crosstalk: A Strange Phenomenon -- 5 Ferroptosis: A Cell Death -- 5.1 Iron Balancing in Ferroptosis -- 5.2 Calcium and Iron Induced Cell Death: Play Collective Role in Oxytosis or Ferroptosis -- 6 Connecting Link to Neurodegeneration: Iron, Calcium, and Ferroptosis -- 6.1 Pantothenate Kinase-Associated Neurodegeneration (PKAN) -- 6.2 Calcineurin -- 6.3 Ryanodine Receptor -- 6.4 Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4) -- 7 Conclusion -- References -- Chapter 7: Iron and Alzheimer´s Disease -- 1 Introduction -- 2 Alzheimer´s Disease -- 2.1 Pathogenesis -- 2.2 Symptoms and Treatments -- 3 Brain Iron Metabolism -- 3.1 What Is Iron? -- 3.2 Iron Absorption and Transport into the Brain -- 3.3 Iron Regulation in the Brain -- 4 Iron and Alzheimer´s Disease: What Is the Interplay? -- 5 Conclusion -- References -- Chapter 8: Iron and Multiple Sclerosis -- 1 Introduction -- 2 Brain-Iron Homeostasis -- 2.1 Iron Uptake in the Brain -- 3 Imaging and Brain Iron in Multiple Sclerosis -- 4 Disruption of Iron Homeostasis in Multiple Sclerosis -- 4.1 Iron Accumulation in Brain -- 4.2 Ferroptosis: Tissue Damage Via Iron Accumulation -- 5 Astrocytes -- 6 Oligodendrocytes -- 7 Grey Matter Iron Accumulation. 8 White Matter Iron Deposition -- 9 Iron Genetic Relation in Multiple Sclerosis -- 10 Iron Chelation Therapy in Multiple Sclerosis -- 11 Chelation Therapy in EAE Model of Multiple Sclerosis -- 11.1 Impact of Brain Iron Accumulation on Cognition and Memory -- 11.2 Brain Iron in Fetus Development -- 11.3 Association of Aging to Iron Induced Neurodegeneration -- 12 Conclusion -- References -- Chapter 9: Iron and Epilepsy -- 1 Introduction -- 1.1 Epilepsy- a Neurological Disorder -- 1.2 Epilepsy Prevalence around the World -- 1.3 Epilepsy in Adults -- 1.4 Risk Factors of Epilepsy -- 1.5 Epilepsy Classification -- 1.6 Seizure -- 1.6.1 The Structure of Classification -- 1.6.2 Classification of Seizure -- 1.6.3 Seizures Are further Classified into Three Based on the Onset (Auvin, 2018) -- 2 Mortality in Epilepsy -- 3 Neuropathology of Epileptic Seizures -- 4 Iron in Brain -- 5 Modulation of Erythropoiesis in the Blood-Brain Barrier (BBB) -- 6 Brain Iron Deposition and Neuronal Death -- 7 Iron in Epilepsy -- 8 Epilepsy Induced by Iron -- 9 Iron Metabolic Process in Epilepsy -- 10 Histopathological Changes in the Epileptic Brain Tissue -- 11 Histopathological Changes in the Iron Induced Epileptic Brain Tissue -- 12 Management of Epilepsy -- 12.1 Initial Management of Epilepsy -- 12.2 Diagnosis of Epilepsy -- 12.3 Pharmaceutical Intervention -- 12.4 Few Common Antiepileptic Drugs (AEDs) -- 12.5 Common Basic Issues Using Anti-Epileptic Drugs -- 12.6 Epilepsy that Is Resistant to Medication -- 12.7 Surgical Therapy -- 12.8 Alternative Treatment Options -- 12.9 Precision Medicine -- 13 Treatment of Epilepsy Induced by Iron -- 14 Conclusion -- References -- Chapter 10: Iron and Subarachnoid Hemorrhage -- 1 Introduction to Subarachnoid Hemorrhage (SAH) -- 2 Epidemiology -- 3 Signs and Symptoms -- 4 Introduction to Iron -- 5 Overview of the Anatomy of Brain. 6 Homeostasis of Iron in the Brain -- 7 Early Brain Injury Post-SAH -- 8 Cerebral Vasospasm Post-SAH -- 9 Role of Iron after SAH -- 10 Body´s Defense against Unbound Heme -- 11 SAH Markers -- 11.1 Hepcidin -- 11.2 Haptoglobin -- 11.3 Haptoglobin Genotype -- 11.4 Total Iron Binding Capacity -- 12 Other Markers -- 13 Heme-Oxygenase 1 -- 14 Ferroptosis -- 15 Biomarker for Ferroptosis -- 16 Ferroptosis and GPX4 -- 17 Ferroptosis and Liproxstatin-1 -- 18 Intracerebral Iron Accumulation -- 19 SAH and Acute Seizures -- 20 SAH and Acute Hydrocephalus -- 21 MRI-QSM (Magnetic Resonance Imaging-Quantitative Susceptibility Mapping) -- 22 Nimodipine and Deferoxamine -- 23 Treatment of Neurotoxicity Caused by HB with Vitreous -- 24 Heat Shock Protein (HSP) and SAH -- 25 Conclusion -- References -- Chapter 11: Iron Deficiency and Psychiatric Disorders -- 1 Introduction -- 2 The Association Between ID and Psychiatric Disorders -- 2.1 Anxiety Disorders -- 2.2 Depressive Disorders -- 2.3 Bipolar Disorders -- 2.4 Schizophrenia and Related Psychoses -- 2.5 ID and Women´s Mental Health -- 2.5.1 Premenstrual Syndrome (PMS) -- 2.5.2 Iron and Pregnancy -- 3 Explaining Mechanisms of the Relationship Between ID and Psychiatric Disorders -- 4 Iron Supplementation and Risk of Psychiatric Disorders -- 5 Conclusion -- References -- Chapter 12: Iron and Neurodevelopmental Disorders -- 1 Introduction -- 2 Role of Iron in Nervous System Development -- 3 Iron and Neurodevelopmental Disorders -- 3.1 Iron and Neural Tube Defects -- 3.2 Iron and Autism Spectrum Disorder -- 3.3 Iron and Attention-Deficit/Hyperactivity Disorder (ADHD) -- 4 Conclusion -- References -- Chapter 13: Iron and Neuropathies -- 1 Introduction -- 2 Iron and Nerve Conduction -- 3 Iron and Neuropathies -- 3.1 Optic Neuropathy -- 3.2 Neurodegeneration with Brain Iron Accumulation (NBIA) -- 3.2.1 Neuroferritinopathy. 3.2.2 Infantile Neuroaxonal Dystrophy. |
| Record Nr. | UNINA-9910635385103321 |
| Gateway East, Singapore : , : Springer, , [2023] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nutrition and Psychiatric Disorders : An Evidence-Based Approach to Understanding the Diet-Brain Connection / / edited by Wael Mohamed, Firas Kobeissy
| Nutrition and Psychiatric Disorders : An Evidence-Based Approach to Understanding the Diet-Brain Connection / / edited by Wael Mohamed, Firas Kobeissy |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (511 pages) |
| Disciplina | 616.9041 |
| Collana | Nutritional Neurosciences |
| Soggetto topico |
Nutrition
Nervous system - Diseases Neurosciences Neurological Disorders Neuroscience |
| ISBN | 9789819726813 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1_Neuroanatomy and Neuropathology of Psychiatric Disorders -- Chapter 2_Biochemical and Neuropharmacology of Psychiatric disorders -- Chapter 3_Human Nutritional Neuroscience: Fundamental Issues -- Chapter 4_ Central Nervous System Regulation of Eating and brain functions -- Chapter 5_Implicated pathways in diet and mental illness -- Chapter 6_Nutrition, the immune and inflammatory systems, and mental illness: what is the interplays -- Chapter 7_the impact of Gut microbiota on mental health -- Chapter 8_Towards better science-based advice on nutrition -- Chapter 9_Chocolate: food for mood -- Chapter 10_Measuring mood in nutritional research -- Chapter 11_The connection between what we eat and our brains throughout the whole life journey -- Chapter 12_Diet and Psychosis -- Chapter 13_Effects of Coffee and Caffeine on Mood and Mood Disorders -- Chapter 14_Deficiencies in vitamins and disease-specific diets impacting on mental health -- Chapter 15_Ketogenic Diet, Mediterranean Diet and Mental health -- Chapter 16_Myths about Diet and Mental Health -- Chapter 17_Psychopharmacology of psychiatric disorders and Food Intake -- Chapter 18_Supplements Effective in the Treatment of Mental Health Conditions -- Chapter 19_Diet and Sleep disorders -- Chapter 20_Nutritional interventions Vs pharmacological interventions -- Chapter 21_The Western Diet Puzzle: Connecting Metabolic Dysfunction to Cognitive and Neurological Consequences -- Chapter 22_Nutritional Psychiatry: the present state of the evidence. |
| Record Nr. | UNINA-9910869164703321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nutrition and psychiatric disorders / / Wael Mohamed, Firas H. Kobeissy, editors
| Nutrition and psychiatric disorders / / Wael Mohamed, Firas H. Kobeissy, editors |
| Pubbl/distr/stampa | Gateway East, Singapore : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (392 pages) |
| Disciplina | 616.89 |
| Collana | Nutritional neurosciences |
| Soggetto topico |
Mental health
Nutrition - Psychological aspects |
| ISBN | 981-19-5021-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Foreword -- Preface -- Acknowledgments -- Contents -- Editors and Contributors -- Part I: Food, Brain Functions, and Behavior -- Chapter 1: Nutrition and Brain Functions in Health and Disease -- 1.1 Introduction -- 1.2 Macronutrients and Brain Functions -- 1.2.1 Amino Acids and Brain Functions -- 1.2.2 Fatty Acids and Brain Functions -- 1.2.2.1 Short-Chain Fatty Acids (SCFAs) -- 1.2.2.2 Medium-Chain Fatty Acids (MCFAs) -- 1.2.2.3 Long-Chain Polyunsaturated Fatty Acids -- 1.3 Micronutrients and Brain Functions -- 1.3.1 Vitamins -- 1.3.1.1 Vitamin A -- 1.3.1.2 B Vitamins -- 1.3.1.3 Vitamin D -- 1.3.1.4 Vitamin C -- 1.3.1.5 Vitamin E -- 1.3.2 Minerals and Brain Functions -- 1.3.2.1 Zinc -- 1.3.2.2 Magnesium (Mg2+) -- 1.3.2.3 Iron (Fe3+) -- 1.3.2.4 Calcium (Ca2+) -- 1.3.2.5 Copper (Cu2+) -- 1.3.2.6 Iodine -- 1.3.2.7 Manganese -- 1.4 Summary and Conclusion -- References -- Chapter 2: Nutrition, Cognitive Functions, and Emotions -- 2.1 Nutrition and Cognition: A Two-Way Street -- 2.2 Macronutrients -- 2.2.1 Carbohydrates -- 2.2.2 Dietary Fatty Acids -- 2.2.3 Proteins -- 2.3 Micronutrients -- 2.3.1 Polyphenols -- 2.3.2 Vitamins and Minerals -- 2.3.3 Vitamin B Family -- 2.3.4 Antioxidant Vitamins (Vitamins E and C) -- 2.3.5 Vitamin D -- 2.3.6 Minerals -- 2.4 Bad Nutrition as an Underpinning Factor in Cognitive/Mood Disorders -- 2.5 Summary and Conclusions -- References -- Chapter 3: Ketogenic Diet: Implications for Treatment and Injury in Neuropsychiatry and Motor Functioning -- 3.1 Introduction -- 3.2 Ketone Body Metabolism -- 3.3 KD Neuroprotection Mechanisms -- 3.3.1 Energy Supplementation -- 3.3.2 Reduction of Inflammation and Oxidative Stress -- 3.3.3 Gut Microbiome Interaction -- 3.3.4 Epigenetic Regulation -- 3.4 KD Effects on Neuropsychiatric Disorders -- 3.4.1 Anxiety and Depression -- 3.4.2 Addiction -- 3.4.3 Other Psychiatric Diseases.
3.5 Evidence for KD Effects in Diseases Associated with Motor Dysfunction -- 3.5.1 Findings from Preclinical Studies -- 3.5.2 Evidence from Clinical Evaluations -- 3.6 Adverse Effects of the Ketogenic Diet -- 3.6.1 Hyperlipidemia -- 3.6.2 Cardiac Disease -- 3.6.3 Linear Growth Failure -- 3.6.4 Gastrointestinal Disorders -- 3.6.5 Kidney Stones -- 3.6.6 Compromised Bone Density -- 3.7 Future Research Directions -- References -- Chapter 4: Effects of Malnutrition on Brain Development -- 4.1 Introduction -- 4.2 Various Macronutrients in the Brain Development -- 4.2.1 Role of Proteins and Brain Development -- 4.2.2 Role of Carbohydrates and Brain Development -- 4.2.3 Role of Fats and Brain Development -- 4.3 Various Micronutrients in the Brain Development -- 4.3.1 Role of Vitamins and Brain Development -- 4.3.1.1 Vitamin B12 -- 4.3.1.2 Vitamin D -- 4.3.2 Role of Minerals and Brain Development -- References -- Chapter 5: Nutrition, Neurotransmitters, and Behavior -- 5.1 Introduction -- 5.2 Role of Some Basic Nutrients -- 5.2.1 Vitamins -- 5.2.2 Minerals -- 5.2.3 Trace Elements -- 5.3 Link Between Nutrition, Neurotransmitters, and Brain Functions -- 5.3.1 GABA -- 5.3.2 Serotonin: 5HT -- 5.3.3 Dopamine -- 5.3.4 Glutamate -- 5.3.5 Acetylcholine -- 5.3.6 Glycine -- 5.4 Conclusion -- References -- Chapter 6: OMICS in Schizophrenia and Alzheimer´s Disease -- 6.1 Introduction -- 6.2 OMICS and Schizophrenia -- 6.3 OMICS and Alzheimer´s Disease (AD) -- 6.4 Conclusion -- References -- Part II: Psychiatric Disorders Related to Nutrition: Deficiency or Overload -- Chapter 7: Effects of Depression and Antidepressant Therapy on Serum Zinc Levels -- 7.1 Introduction -- 7.2 Potential Antidepressant Mechanisms of Zinc -- 7.3 Experimental Animal Studies -- 7.4 Clinical Studies -- 7.5 Conclusions -- References -- Chapter 8: Nutrition and Depression -- 8.1 Introduction. 8.2 Epidemiology -- 8.2.1 Dietary Patterns -- 8.2.1.1 Dietary Inflammatory Index (DII) -- 8.2.2 Epidemiological Evidence Relating Dietary Patterns to Depression -- 8.2.2.1 Mediterranean Diet -- 8.2.2.2 Dietary Inflammatory Index/Alternative Dietary Inflammatory Index -- 8.2.2.3 ``Healthy´´ Diet -- 8.2.2.4 High-Fat/Sugar Diet -- 8.2.2.5 Other Dietary Patterns -- 8.2.2.6 Specific Food Components -- 8.2.2.7 Red Meat and Processed Meat -- 8.2.2.8 Other Food Types -- Tea -- Coffee and Caffeine -- Grain -- Others -- 8.2.2.9 Nutrients -- 8.2.2.10 Macronutrients (Fig. 8.1) -- Proteins -- Fat -- Polyunsaturated Fatty Acid (PUFA) -- Carbohydrate -- 8.2.2.11 Micronutrients -- 8.2.2.12 B Vitamins -- 8.2.2.13 Antioxidants -- Vitamin C (Ascorbic Acid) -- Vitamin E -- Selenium (Se) -- 8.2.2.14 Vitamin D -- 8.2.2.15 Magnesium -- 8.2.2.16 Oxidant and Antioxidant -- 8.2.2.17 Gut Microbiota -- 8.2.2.18 Trace Minerals -- Iron -- Zinc (Zn) -- Selenium (Se) -- 8.3 Potential Mechanism -- 8.4 Preventive, Protective, and Therapeutic Role of Diet in Depression -- 8.4.1 Dietary Pattern -- 8.4.2 Macronutrients -- 8.4.2.1 Proteins -- 8.4.2.2 Fats -- 8.4.2.3 Carbohydrates -- 8.4.3 Vitamins and Trace Elements -- 8.4.3.1 Vitamins -- 8.4.3.2 Trace Elements -- 8.5 Depressive Disorders Among Other Groups -- 8.5.1 Geriatric Depression and Nutrition -- 8.5.2 Child and Adolescent Depression and Nutrition -- 8.5.3 Postpartum Depression and Nutrition -- 8.6 Limitations of Existing Evidence on Nutrition and Depression -- 8.7 Future Directions -- 8.8 Conclusion -- References -- Chapter 9: Nutritional Deficiencies in Obsessive-Compulsive Disorder and Possible Treatment Interventions -- 9.1 Introduction -- 9.2 Obsessions and Compulsions -- 9.3 Nutritional Deficiencies and Obsessive-Compulsive Disorder -- 9.3.1 Amino Acids and Derivatives -- 9.3.1.1 Glutamate -- 9.3.1.2 Glycine. 9.3.1.3 N-acetyl Cysteine -- 9.3.2 Plants and Derivatives -- 9.3.2.1 Borage -- 9.3.2.2 Curcumin -- 9.3.2.3 Milk Thistle -- 9.3.2.4 St. John´s Wort -- 9.3.2.5 Valerian Root -- 9.3.3 Vitamins -- 9.3.3.1 Vitamin B9 -- 9.3.3.2 Vitamin B12 -- 9.3.3.3 Vitamin C -- 9.3.3.4 Vitamin D -- 9.3.3.5 Vitamin E -- 9.3.4 Trace Minerals -- 9.3.4.1 Zinc -- 9.3.4.2 Selenium -- 9.3.5 Others -- 9.3.5.1 Myoinositol -- 9.3.5.2 Omega-3 Fatty Acids -- 9.4 Conclusions -- References -- Chapter 10: Caffeine, Mental Well-Being, and Psychiatric Disorders -- 10.1 Introduction -- 10.2 Caffeine Pharmacodynamic -- 10.2.1 Caffeine Pharmacokinetics -- 10.3 Caffeine and Addiction -- 10.4 Caffeine and Sleep Disorder -- 10.5 Caffeine and Attention Deficit/Hyperactivity Disorder (ADHD) -- 10.6 Caffeine and Anxiety Disorders -- 10.7 Caffeine and Alzheimer´s Disease -- 10.8 Caffeine and Parkinson´s Disease -- 10.9 Caffeine and Mood Disorder -- 10.9.1 Bipolar Related Disorder -- 10.9.2 Depressive Disorder -- 10.9.3 Electroconvulsive Therapy (ECT) -- 10.10 Caffeine and Psychotic Disorder -- 10.11 Caffeine and Psychiatric Medication Interactions -- 10.12 Conclusions -- References -- Chapter 11: Biopsychology of Chocolate Craving -- 11.1 Background -- 11.2 Chocolate Composition and Psychopharmacologic Active Components -- 11.2.1 Overview -- 11.2.2 Polyphenols -- 11.2.3 Biogenic Amines -- 11.2.4 Methylxanthines -- 11.2.5 Cannabinoid-Like Fatty Acids -- 11.2.6 Magnesium -- 11.2.7 Concluding Remarks -- 11.3 Chocolate Intake Patterns -- 11.3.1 Chocolate Addiction -- 11.3.2 Assessing Chocolate Craving: How to Discriminate Between Chocolate Cravers and Non-cravers? -- 11.4 Chocolate as Social Drug -- 11.5 The Effects of Chocolate on Mood -- 11.6 Is Chocolate Craving Gender Driven? -- 11.7 Concluding Remarks -- Appendix 11.1 Attitudes to Chocolate Questionnaire (ACQ) (Benton et al. 1998). Appendix 11.2 Orientation to Chocolate Questionnaire (OCQ) (Cartwright and Stritzke 2008) -- References -- Chapter 12: Food Addiction -- 12.1 Introduction to Food Addiction: Is Food Addiction a True Medical Disorder? -- 12.2 Epidemiology and Risk Factors of Food Addiction -- 12.3 Neurobiology of Food Addiction -- 12.4 Food Addiction Conceptualized from a Substance-Use Disorder Perspective -- 12.5 Food Addiction and DSM-5-TR Criteria -- 12.6 Signs and Symptoms of Food Addiction -- 12.7 Food Addiction Scales -- 12.8 Food Addiction and Impact on Physical Health -- 12.9 Food Addiction and Mental Health -- 12.10 Mindful Eating Amid Fast Food Availability -- 12.11 Evidence-Based Treatment Interventions for Food Addiction -- 12.12 Conclusions -- References -- Chapter 13: Nutrition and Anxiety Disorders -- 13.1 Introduction -- 13.1.1 What Are Anxiety Disorders? -- 13.1.2 How Does Anxiety Could Be Related to Nutrition? -- 13.1.3 Food and Brain Functions -- 13.1.4 Can Diet Modification or Healthy Diet Improve the Anxiety? -- 13.2 Food Improving Anxiety -- 13.3 Dietary Patterns Causing Anxiety -- 13.4 Food Causing Anxiety -- 13.4.1 Relationships Between Caffeine and Anxiety -- 13.4.2 Other Types of Food Related to Anxiety -- 13.5 New Food Dimension -- 13.6 Anxiety, Stress, and Inflammation -- 13.7 Microbiome and Mental Health -- 13.8 Conclusion -- References -- Chapter 14: Nutrition and Substance-Use Disorder -- 14.1 Introduction -- 14.2 Types and Mechanisms of SUDs -- 14.2.1 Stimulant-Use Disorder -- 14.2.2 Opioid-Use Disorder -- 14.2.3 Alcohol-Use Disorder -- 14.2.4 Sedative-Use Disorder -- 14.2.5 Cannabis-Use Disorder -- 14.3 Nutrition and SUD -- 14.3.1 Malnutrition and Substance-Use Disorders -- 14.3.2 Etiology of Malnutrition in SUD -- 14.3.3 Nutritional Deficiencies and SUD -- 14.3.4 The Psychology Behind Malnutrition and Appetite Alteration in SUD. 14.3.5 Nutrition and Recovery of SUD. |
| Record Nr. | UNINA-9910616374803321 |
| Gateway East, Singapore : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nutrition in Brain Aging and Dementia / / edited by Nasrollah Moradikor, Indranath Chatterjee, Wael Mohamed
| Nutrition in Brain Aging and Dementia / / edited by Nasrollah Moradikor, Indranath Chatterjee, Wael Mohamed |
| Autore | Moradikor Nasrollah |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (324 pages) |
| Disciplina | 570 |
| Altri autori (Persone) |
ChatterjeeIndranath
MohamedWael |
| Collana | Nutritional Neurosciences |
| Soggetto topico |
Biology
Neurosciences Neural networks (Neurobiology) Nervous system - Diseases Nutrition Biological Sciences Neuroscience Systems Neuroscience Neurological Disorders |
| ISBN |
9789819741175
9789819741168 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Pathogenesis of Dementia -- 2. Genetic and Non-Genetic Risk Factors for Dementia -- 3. Symptoms and Diagnosis of Dementia -- 4. Biomarkers in Dementia Research -- 5. Neurocognitive Aspects of Dementia -- 6. Role of Nutrition in Maintaining Brain Health -- 7. Micronutrients for dementia prevention -- 8. Exploring functional foods in prevention of dementia -- 9. Alterations in trace elements and dementia -- 10. Carotenoids in Alzheimer's Disease and Dementia -- 11. Probiotic agents for Alzheimer and dementia -- 12. Traditional Herbal Medicine for Dementia Therapy -- 13. Non-pharmacological approaches for dementia management -- 14. Dietary Recommendations for Managing Dementia. |
| Record Nr. | UNINA-9910882900503321 |
Moradikor Nasrollah
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Role of micronutrients in brain health / / edited by Wael Mohamed and Toshihide Yamashita
| Role of micronutrients in brain health / / edited by Wael Mohamed and Toshihide Yamashita |
| Pubbl/distr/stampa | Gateway East, Singapore : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (313 pages) |
| Disciplina | 616.8 |
| Collana | Nutritional Neurosciences |
| Soggetto topico |
Brain - Diseases
Neuroprotective agents Trace elements in nutrition |
| ISBN |
981-16-6467-6
981-16-6466-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Foreword -- Preface -- Acknowledgments -- Contents -- Editors and Contributors -- Part I: Micronutrients and Brain Functions -- Chapter 1: Micronutrients and Neurogenesis -- 1.1 Introduction -- 1.2 Neurogenesis in Early Development of CNS -- 1.3 Neurogenesis in the Adult Brain -- 1.4 The Role of Micronutrients in Neurogenesis -- 1.5 Copper -- 1.6 Iodine -- 1.7 Iron -- 1.8 Zinc -- 1.9 Vitamin D -- 1.10 Conclusion -- References -- Chapter 2: Vitamin E and Cognitive Functions: What Is the Interplay? -- 2.1 Introduction -- 2.2 Animal Studies and Vitamin E -- 2.3 Human Studies and Vitamin E -- 2.3.1 Epidemiological Studies -- 2.3.2 Clinical Trials -- 2.4 Critical Analysis and Reflection on Vitamin E Neuroprotective Effects -- 2.5 Conclusion -- References -- Chapter 3: Gut-Brain Cross Talk: Microbiome and Micronutrients -- 3.1 Introduction -- 3.2 Human Gut Microbiome -- 3.3 Diet, Micronutrient, and Immune Function -- 3.4 Gut-Brain Axis -- 3.4.1 How Gut Microbiota Can Influence the Brain? -- 3.4.2 How Can the Brain Influence the Gut Microbiota? -- 3.5 Neurodevelopmental Disorder -- 3.6 Parkinson Disease -- 3.7 Conclusion -- References -- Chapter 4: Iodine: A Critical Micronutrient in Brain Development -- 4.1 Background -- 4.2 Effect of Iodine on Brain Function Across the Lifespan -- 4.3 Mechanism of Action and Interaction of Iodine, Thyroid Hormone, and the Brain -- 4.3.1 Hippocampus -- 4.3.2 Myelin -- 4.3.3 Neurotransmitters -- 4.4 Conclusion -- References -- Chapter 5: Tocotrienols: Mother Nature´s Gift to the Brain -- 5.1 Introduction -- 5.2 Tocopherols and Tocotrienols -- 5.3 Neurology -- 5.4 Alzheimer´s Disease -- 5.5 Parkinson´s Disease -- 5.6 Stroke -- 5.7 Brain Cancer -- 5.8 Traumatic Brain Injury -- 5.9 Conclusion -- References -- Part II: Micronutrients and Brain Disorders.
Chapter 6: Micronutrients and Depression: Is There Any Association? -- 6.1 Nutrition and its Association with Depression -- 6.2 Pathophysiological Mechanisms of Dietary Elements and Contribution to Depression -- 6.2.1 Serotonin -- 6.2.2 Polyunsaturated Fatty Acids -- 6.2.3 Monosaturated Fatty Acids -- 6.2.4 Saturated Fatty Acids -- 6.2.5 Trans Fatty Acids -- 6.2.6 Refined Sugars -- 6.2.7 Gut Microbiome -- 6.2.8 Micronutrients -- 6.3 Dietary Pattern and Depression -- 6.4 Conclusion -- References -- Chapter 7: Micronutrients and Epilepsy -- 7.1 Introduction -- 7.2 Vitamins -- 7.2.1 Vitamin B -- 7.2.1.1 Vitamin B6 -- 7.2.1.2 Vitamin B9 -- 7.2.1.3 Vitamin B1, B7, and B12 -- 7.2.2 Vitamin D -- 7.2.3 Vitamin E -- 7.2.4 Vitamin K -- 7.2.5 Vitamin C -- 7.2.6 Vitamin A -- 7.2.7 Coenzyme Q10 -- 7.3 Minerals -- 7.3.1 Calcium -- 7.3.2 Magnesium -- 7.4 Trace Elements -- 7.4.1 Manganese -- 7.4.2 Iron -- 7.4.3 Zinc -- 7.4.4 Copper -- 7.4.5 Selenium -- 7.5 Conclusion -- References -- Chapter 8: Cognitive and Behavioral Consequences of Brain Iron Deficiency -- 8.1 Background -- 8.2 Brain Iron: Homeostasis and Function -- 8.3 Effect of Iron Deficiency on Cognitive Development -- 8.4 Early-Life Iron Deficiency: Pathological Brain Changes -- 8.5 Effects of Iron Deficiency on Cognitive Performance in School -- 8.6 Does Iron Supplementation in School Children Improve Cognitive Performance? -- 8.7 Conclusion -- References -- Chapter 9: Micronutrients and Parkinson´s Disease -- 9.1 Introduction -- 9.2 Oxidative Stress in Parkinson´s Disease -- 9.3 Gut Dysbiosis in Parkinson´s Disease -- 9.4 Nutrients and its Protective Effects in Parkinson´s Disease -- 9.4.1 Micronutrients -- 9.4.1.1 Vitamin B1 (Thiamine) -- 9.4.1.2 Vitamin B6, B12, and Folate -- 9.4.1.3 Niacin (Vitamin B3) -- 9.4.1.4 Riboflavin (Vitamin B2) -- 9.4.1.5 Vitamin C -- 9.4.1.6 Vitamin D -- 9.4.1.7 Vitamin E. 9.4.1.8 Coenzyme Q10 -- 9.4.1.9 Fish Oils (ω-3 Fatty Acids) -- 9.4.2 Phytochemicals -- 9.4.2.1 Caffeine -- 9.4.2.2 Mediterranean Diet -- 9.4.3 Other Nutrients -- 9.4.3.1 Probiotics -- 9.4.3.2 Prebiotics and Synbiotics -- 9.4.3.3 Dairy Products -- 9.5 Nutritional Aspects of Parkinson´s Disease -- 9.5.1 Nutritional Evaluation -- 9.5.2 Managing Nutritional Issues in PD -- 9.6 Conclusion -- References -- Chapter 10: Malnutrition of Micronutrients and Brain Disorders -- 10.1 Introduction -- 10.2 Gut Microbiota -- 10.3 Nutrition and Malnutrition Definitions -- 10.4 Micronutrients -- 10.4.1 Food Guides History -- 10.4.2 Food Guides Groups -- 10.4.3 Food Groups Serving Sizes -- 10.5 The Prevalence of Malnutrition Diseases -- 10.6 Factors Affecting the Malnutrition State -- 10.7 The Nutritional Assessments Process -- 10.8 Malnutrition and the Brain Disorders -- 10.8.1 Dietary Intervention and Parkinson Disease (PD) -- References -- Chapter 11: Connections Between Micronutrients, Cerebral Monoamines and Related Brain Disorders -- 11.1 Introduction -- 11.2 Overview: Synthesis, Activity, and Metabolism of Serotonin and Histamine -- 11.2.1 Serotonin -- 11.2.2 Histamine -- 11.3 Effects of Dietary Micronutrients on Cerebral Biogenic Amine Levels: Serotonin and Histamine -- 11.3.1 Substrates (Tryptophan for Serotonin and Histidine for Histamine) -- 11.3.1.1 Tryptophan -- 11.3.1.2 Histidine -- 11.3.2 Vitamins and Cofactors -- 11.3.2.1 Thiamine (Vitamin B1) -- 11.3.2.2 Niacinamide/Niacin (Vitamin B3) -- 11.3.2.3 Pyridoxine (Vitamin B6) / Pyridoxal L-Phosphate (PLP) -- 11.3.2.4 Ascorbic Acid (Vitamin C) -- 11.3.2.5 Calcitrol (Vitamin D Hormone) -- 11.3.3 Cofactors -- 11.3.3.1 Tetrahydrobiopterin (BH4) -- 11.3.3.2 Copper -- 11.3.3.3 Zinc -- 11.4 Cerebral Serotonin, Cerebral Histamine and Associated Brain Disorders -- 11.4.1 Addiction/Compulsion and Pain -- 11.4.2 Autism. 11.4.3 Dementia / Neurodegenerative Diseases -- 11.4.4 Depression -- 11.4.5 Eating Disorders and Metabolic Syndrome -- 11.4.6 Epilepsy -- 11.4.7 Schizophrenia -- 11.4.8 Sleep -- 11.4.9 Stress -- 11.4.10 Vestibular Deficits -- 11.5 Concluding Remarks on Cross Talk between Cerebral Histamine and Serotonin -- References -- Chapter 12: Micronutrients and Autism Spectrum Disorder -- 12.1 Background and Significance -- 12.2 Incidence and Prevalence of ASD -- 12.3 Micronutrients and ASD: What Is the Interplay? -- 12.3.1 Maternal Diet Condition -- 12.3.2 Dietary Intake of Children with ASD -- 12.3.3 Breastfeeding -- 12.4 The Gut-Brain Axis and its Role to ASD -- 12.5 Dietary Approach for ASD -- 12.6 Conclusions and Recommendations -- References -- Part III: Micronutrients as Therapeutics -- Chapter 13: Edible Bird´s Nest as Brain Food -- 13.1 Introduction and Historical Background of EBN -- 13.2 Preparation and Extraction of EBN -- 13.3 Active Compounds in Edible Bird´s Nest -- 13.4 Pharmacological Effect of Edible Bird´s Nest -- 13.4.1 Antiviral Effect of EBN -- 13.4.2 Effect of EBN on Cell Proliferation -- 13.4.3 Antioxidant Effect of EBN -- 13.4.4 Bone Regeneration Effect of EBN -- 13.5 Effects of EBN on Learning and Memory -- 13.6 EBN and AD Rat Model -- 13.7 Conclusions and Recommendations -- References -- Chapter 14: Phytochemicals as Micronutrients: What Is their Therapeutic Promise in the Management of Traumatic Brain Injury? -- 14.1 Traumatic Brain Injury -- 14.2 Conventional Management of Traumatic Brain Injury -- 14.3 Phytochemicals as Alternative Therapeutic Interventions -- 14.4 Phytochemicals in TBI Management -- 14.4.1 Ginseng -- 14.4.2 Curcumin -- 14.4.3 Baicalein -- 14.4.4 Apocynin -- 14.4.5 Genistein -- 14.4.6 Coumarin -- 14.5 Conclusion -- References. Chapter 15: Phytochemicals as Micronutrients: What Is their Therapeutic Promise in the Management of Alzheimer´s Disease? -- 15.1 Alzheimer´s Disease -- 15.2 Conventional Management of Alzheimer´s Disease -- 15.3 Phytochemicals as Alternative Therapeutic Interventions -- 15.4 Phytochemicals in Neurological Disorders -- 15.5 Phytochemicals in AD Management -- 15.6 Ginkgo Biloba -- 15.7 Piper Nigrum -- 15.8 Ficus Carica -- 15.9 Withania Somnifera -- 15.10 Olea Europaea -- 15.11 Lavandula Angustofolia -- 15.12 Curcumin Longa -- 15.13 Nigella Sativa -- 15.14 Panax Ginseng -- 15.15 Conclusion -- References. |
| Record Nr. | UNINA-9910743361203321 |
| Gateway East, Singapore : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||